Pediatric medical cannabis is cannabis or a cannabis-derived medicine given to a person under 18 for a diagnosed condition, and it should only be considered with a pediatric specialist involved. The strongest evidence covers a small number of severe epilepsy syndromes; for most other childhood conditions the research is thin, and any decision has to weigh possible symptom relief against developmental and safety risks.

pediatric medical cannabis dosing chart by weight

What counts as pediatric medical cannabis?

The phrase covers several very different things, and treating them as one category causes confusion:

medical cannabis for children with epilepsy

  • Prescription cannabinoid medicine. The FDA has approved a purified cannabidiol (CBD) oral solution for seizures linked to Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. It is a regulated drug with defined dosing, not a dispensary product.
  • State medical cannabis programs. Some states allow minors to qualify with a physician's certification, usually for a specific list of qualifying conditions, and often with extra requirements attached.
  • Over-the-counter CBD. Sold without a prescription and not FDA-approved for any pediatric condition. Potency, purity, and labeling vary from bottle to bottle.

What does the evidence support?

Research in children is limited, and it is uneven across conditions:

more on this topic

  • Severe childhood epilepsies: the most studied area, with randomized trial data behind the approved prescription CBD medicine.
  • Chemotherapy-related nausea and vomiting, and some spasticity: mixed results, with most data coming from adults.
  • Autism, ADHD, anxiety, chronic pain, and inflammatory bowel disease: early or small studies only. Promising in some reports, not proven.

Limited evidence is not the same as proof of harm, but it does mean families are often trying something experimental. That is a decision to make with a clinician, not with a product label.

related article

Why children are not small adults

  • Brain development. The brain keeps maturing into the mid-20s. THC acts on the endocannabinoid system, and repeated exposure during adolescence has been associated with changes in memory, attention, and learning.
  • Weight-based dosing. Pediatric doses are typically calculated per kilogram of body weight, and children metabolize drugs at different rates than adults.
  • Sensitivity to THC. Young patients tend to feel psychoactive effects, sedation, and mood shifts more strongly.
  • Drug interactions. CBD can raise blood levels of some antiseizure medications, which calls for monitoring and dose changes managed by a prescriber.

Legal access in the United States

Cannabis remains illegal under federal law, with the exception of FDA-approved products. State medical programs write their own rules for minors, and those rules differ from state to state:

  • Some states require certification by a pediatric specialist or sign-off from a second physician.
  • Some cap THC content for minors or require a parent or guardian to purchase and administer the product.
  • Schools and childcare settings may not allow the product on site, even with a valid patient card.

Safety steps that matter at home

  • Store everything locked and out of sight. Edibles look like candy and are a common cause of unintentional ingestion in young children.
  • Keep a written log: product, batch number, dose, time, and response.
  • Buy from licensed sources only. Unregulated products have tested positive for contaminants and carried inaccurate cannabinoid labels.
  • Avoid smoked and vaped forms for children because of lung exposure.
  • Tell the whole care team, including the pharmacist, about every product in use.
  • Never stop a prescribed medication on your own to try cannabis instead.

Questions to ask a pediatric specialist

  1. What diagnosis are we treating, and how strong is the evidence for this condition?
  2. Are there approved treatments we have not tried yet?
  3. What dose, form, and schedule, and who adjusts it if side effects appear?
  4. What interactions or side effects should we watch for?
  5. How will we measure whether it is working, and when would we stop?

A note on dispensaries

Cannabis shops are retail settings, not pediatric clinics. Staff can explain products, lab results, and state paperwork for adult patients, but they should not be setting doses for a child. Decisions about pediatric medical cannabis belong with the child's physicians, and any dispensary purchase for a minor should follow the state's caregiver rules exactly. At Eden Cannabis, pediatric questions are directed back to the family's care team.

The bottom line

Pediatric medical cannabis is a narrow option with real risks, not a general wellness product for kids. For a small group of severe epilepsy patients, an approved CBD medicine has changed outcomes. For everything else, the honest answer is that the science is still catching up, and careful medical supervision is what keeps a child safe.